Wockhardt Limited (WOCKPHARMA.NS) NSE
1,966.20
-186.7(-8.67%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,966.20
-186.7(-8.67%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2386
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Huzaifa Habil Khorakiwala | Executive Director | 25.2M | 1971 |
| Murtaza Habil Khorakiwala | MD & Executive Director | 25.2M | 1973 |
| Habil Fakhruddin Khorakiwala | Founder & Executive Chairman | 37.4M | 1941 |
| Sachin Bhagwat | Chief Scientific Officer | 0 | N/A |
| Anil V. Kamath AMRSH MBIM MIMA | Senior Vice President of Business Development | 0 | 1951 |
| Deepak Madnani | Chief Financial Officer | 0 | N/A |
| Satej Mehta | Head of Human Resource | 0 | N/A |
| Zoher T. Sihorwala | Head of Global Regulatory Affairs | 0 | 1970 |
| Debolina Partap | Senior Vice President of Legal | 0 | N/A |
| Rashmi Dinesh Mamtura | Company Secretary & Compliance Officer | 0 | N/A |
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company's biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. It also provides contract manufacturing services for sterile injectables, lyophilization, and other dosage forms; and research services. The company was founded in 1967 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.